Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Loss of TET2 Promotes CD8+ T Cell Memory Differentiation
Shannon A. Carty, Mercy Gohil, Lauren B. Banks, et al.
The Journal of Immunology (2017) Vol. 200, Iss. 1, pp. 82-91
Open Access | Times Cited: 144

Showing 1-25 of 144 citing articles:

TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
Omar Khan, Josephine R. Giles, Sierra McDonald, et al.
Nature (2019) Vol. 571, Iss. 7764, pp. 211-218
Open Access | Times Cited: 1202
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
Joseph A. Fraietta, Christopher L. Nobles, Morgan A. Sammons, et al.
Nature (2018) Vol. 558, Iss. 7709, pp. 307-312
Open Access | Times Cited: 703
Brain immunology and immunotherapy in brain tumours
John H. Sampson, Michael D. Gunn, Peter E. Fecci, et al.
Nature reviews. Cancer (2019) Vol. 20, Iss. 1, pp. 12-25
Open Access | Times Cited: 532
Engineering CAR-T Cells for Next-Generation Cancer Therapy
Mihe Hong, Justin Clubb, Yvonne Y. Chen
Cancer Cell (2020) Vol. 38, Iss. 4, pp. 473-488
Open Access | Times Cited: 486
Targeting the epigenetic regulation of antitumour immunity
Simon J. Hogg, Paul A. Beavis, Mark A. Dawson, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 11, pp. 776-800
Closed Access | Times Cited: 449
Epigenetic control of CD8+ T cell differentiation
Amanda N. Henning, Rahul Roychoudhuri, Nicholas P. Restifo
Nature reviews. Immunology (2018) Vol. 18, Iss. 5, pp. 340-356
Open Access | Times Cited: 424
T cells in health and disease
Lina Sun, Yanhong Su, Anjun Jiao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 359
The emerging role of epigenetic therapeutics in immuno-oncology
Michael J. Topper, Michelle Vaz, Kristen A. Marrone, et al.
Nature Reviews Clinical Oncology (2019) Vol. 17, Iss. 2, pp. 75-90
Open Access | Times Cited: 344
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Enyong Dai, Zhi Zhu, Shudipto Wahed, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 187
Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets
Jing Yang, Jin Xu, Wei Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 152
Clonal hematopoiesis and non-hematologic disorders
Siddhartha Jaiswal
Blood (2020)
Open Access | Times Cited: 147
TET2 guards against unchecked BATF3-induced CAR T cell expansion
Nayan Jain, Zeguo Zhao, Judith Feucht, et al.
Nature (2023) Vol. 615, Iss. 7951, pp. 315-322
Open Access | Times Cited: 85
Metabolic programs tailor T cell immunity in viral infection, cancer, and aging
Sofie Hedlund Møller, Pei‐Chun Hsueh, Yi-Ru Yu, et al.
Cell Metabolism (2022) Vol. 34, Iss. 3, pp. 378-395
Open Access | Times Cited: 78
Clonal haematopoiesis and dysregulation of the immune system
Roger Belizaire, Waihay J. Wong, Michelle L. Robinette, et al.
Nature reviews. Immunology (2023) Vol. 23, Iss. 9, pp. 595-610
Closed Access | Times Cited: 65
Metabolism and epigenetics at the heart of T cell function
Leticia Soriano‐Baguet, Dirk Brenner
Trends in Immunology (2023) Vol. 44, Iss. 3, pp. 231-244
Open Access | Times Cited: 44
TET Enzymes in the Immune System: From DNA Demethylation to Immunotherapy, Inflammation, and Cancer
Isaac F. López-Moyado, Myunggon Ko, Patrick G. Hogan, et al.
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 455-488
Closed Access | Times Cited: 25
Vitamin C and immune cell function in inflammation and cancer
Abel Damien Ang, Juliet M. Pullar, Margaret J. Currie, et al.
Biochemical Society Transactions (2018) Vol. 46, Iss. 5, pp. 1147-1159
Open Access | Times Cited: 157
Transcriptional and Epigenetic Regulation of Effector and Memory CD8 T Cell Differentiation
Yao Chen, Ryan Zander, Achia Khatun, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 141
Dysregulation of the TET family of epigenetic regulators in lymphoid and myeloid malignancies
Chan‐Wang Jerry Lio, Hiroshi Yuita, Anjana Rao
Blood (2019) Vol. 134, Iss. 18, pp. 1487-1497
Open Access | Times Cited: 124
TET Enzymes and 5hmC in Adaptive and Innate Immune Systems
Chan‐Wang Jerry Lio, Anjana Rao
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 119
CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration
Christopher L. Nobles, Scott Sherrill-Mix, J.K. Everett, et al.
Journal of Clinical Investigation (2019) Vol. 130, Iss. 2, pp. 673-685
Open Access | Times Cited: 108
In vivo CRISPR screening reveals nutrient signaling processes underpinning CD8+ T cell fate decisions
Hongling Huang, Peipei Zhou, Jun Wei, et al.
Cell (2021) Vol. 184, Iss. 5, pp. 1245-1261.e21
Open Access | Times Cited: 103
Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapy
Peter G. Miller, Adam S. Sperling, Elliott J. Brea, et al.
Blood Advances (2021) Vol. 5, Iss. 15, pp. 2982-2986
Open Access | Times Cited: 93
Engineering better chimeric antigen receptor T cells
Hao Zhang, Pu Zhao, He Huang
Experimental Hematology and Oncology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 85
Role of Methylation in Pro- and Anti-Cancer Immunity
Ali Mehdi, Shafaat A. Rabbani
Cancers (2021) Vol. 13, Iss. 3, pp. 545-545
Open Access | Times Cited: 80
Page 1 - Next Page

Scroll to top